stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Inhibikase Therapeutics IncIKT
$1.557.19%-0.12
Dopo l'orario di chiusura: 1.53-0.02 -1.29%

Inhibikase Therapeutics Inc (IKT)

Date: 2026-10-30 16:00O: 1.67H: 1.67L: 1.52C: 1.55Vol: 438.0k
Precedente Chiudi:
$1.67
Aprire:
$1.67
Volume 24 ore:
437,986
Volume relativo:
0.66
Capitalizzazione di mercato:
$216.28M
Reddito:
$79,600
Utile/perdita netta:
-$48.26M
Rapporto P/E:
-
EPS:
-$0.4922
Flusso di cassa netto:
-$28.24M
1W Prestazione:
-2.52%
1M Prestazione:
-24.57%
6M Prestazione:
-17.99%
1Y Prestazione:
+6.16%
Intervallo 1D:
$1.52$1.67
Intervallo di 1 settimana:
$1.50$1.70
Portata 52W:
$1.33$2.61

Profilo aziendale di Inhibikase Therapeutics Inc (IKT)

Nome
Inhibikase Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(302) 295-3800
Indirizzo
1000 N. WEST STREET, SUITE 1200, WILMINGTON, USA
Dipendente
35
X
-
Prossima data di guadagno
2026-11-13
Ultimi documenti SEC
SEC
Discussioni di IKT su X
X

Confronta IKT con VRTX, REGN, MRNA, ARGX, ONC

AzioniPrezzoCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
IKT
Inhibikase Therapeutics Inc
$1.55$216.28M$79,600-$48.26M-$28.24M-$0.4922
VRTX
Vertex Pharmaceuticals Inc
$558.88$141.65B$12.34B$4.34B$3.71B$16.87
REGN
Regeneron Pharmaceuticals Inc
$927.89$95.53B$14.92B$4.42B$3.79B$41.04
MRNA
Moderna Inc
$221.72$88.52B$2.23B-$3.19B-$1.60B-$8.15
ARGX
Argen X Se Adr
$892.87$56.15B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$370.33$41.89B$5.76B$514.49M$1.10B$4.48

Inhibikase Therapeutics Inc Azioni (IKT) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-13IniziatoChardan Capital MarketsNeutral
2026-06-10IniziatoOppenheimerOutperform
2026-03-04IniziatoLadenburg ThalmannBuy
2026-01-21IniziatoBofA SecuritiesBuy

Inhibikase Therapeutics Inc Azioni (IKT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Inhibikase Therapeutics Inc Azioni (IKT) insider trading

Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Sands Capital Life Sciences Pu10% OwnerNov 21 '25Buy$1.452,068,9652,999,99913,018,965

Inhibikase Therapeutics Inc Borsa (IKT) Ultime notizie

Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 13, 2026
Oct 13, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Aug 26, 2026
Aug 26, 2026
Aug 21, 2026
Aug 21, 2026
Aug 21, 2026
Aug 21, 2026
Aug 19, 2026
Aug 19, 2026
Aug 18, 2026
Aug 18, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 16, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026

Simile a IKT